TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/05/2024
Back to search
Official data from USPTO
FRONTELYN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
02/05/2024
Trademark type
Combined
Nice classes
5, 35, 42
Filing date
08/20/2021
Registration date
08/15/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/15/2023
Last transaction
02/05/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
5
Owner type
03
Owner location
Guangzhou, Guangdong, CN
Examiner
BLOHM, LINDA
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized term "FRONTELYN".
Holders and representatives
Holders
Akeso Pharmaceuticals, Inc.
Representatives
Robert J. Kenney Willcox & Savage, P.C.
Technical classification
Nice Classes
Class 5Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of cancerinflammationblood diseasesasthmaskin disease and hypercholesterolemia; vaccines; biochemical medicines for the treatment of cancerinflammationblood diseasesasthmaskin disease and hypercholesterolemia; chemico-pharmaceutical preparations for the treatment of cancerinflammationblood diseasesasthmaskin disease and hypercholesterolemia; biological preparations for the treatment of cancerinflammationblood diseasesasthmaskin disease and hypercholesterolemia for medical purposes; hemoglobin; medicines for the treatment of cancerinflammationblood diseasesasthmaskin disease and hypercholesterolemia for human purposes; Drugspharmaceutical preparations for the treatment of cancerinflammationblood diseasesasthmaskin disease and hypercholesterolemia for human purposes; hematogen for the treatment of cancerinflammationblood diseasesasthmaskin disease and hypercholesterolemia; injectable medicinal solutions for the treatment of cancerinflammationblood diseasesasthmaskin disease and hypercholesterolemia
Class 35
Retail store services and wholesale store services featuring medicines; Retail store services and wholesale stole services featuring pharmaceutical preparations; Retail store services and wholesale store services featuring sanitary preparations; Retail store services and wholesale store services featuring medical supplies; advertising and publicity services; publicity; organization of exhibitions and events for commercial or advertising purposes; marketing the goods and services of others by providing hyperlinks to websites of others; demonstration of goods; conducting market studies; business appraisals; business investigations; retail store services featuring pharmaceuticalveterinary and sanitary preparations and medical supplies; wholesale store services featuring pharmaceuticalveterinary and sanitary preparations and medical supplies; import-export agency services
Class 42
Technological research in the field of medicines and pharmaceutical preparations; research and development of new products for others; scientific laboratory services; product quality testing; conducting technical project studies in the nature of research in the field of pharmaceutical studies; chemical research; chemistry servicesresearch in the field of chemistry; chemical analysis; biological research; bacteriological research; medical and scientific researchconducting clinical trials for others; scientific research
Publications
History of USPTO decisions and trademark events.
25 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/05/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/05/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/15/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
08/15/2023
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
07/13/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
07/13/2023
IUCN
NOTICE OF ALLOWANCE CANCELLED
05/12/2023
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
05/12/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/02/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/07/2023
PUBO
PUBLISHED FOR OPPOSITION
03/07/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/15/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/01/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/27/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/27/2023
ALIE
ASSIGNED TO LIE
01/27/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/28/2022
DOCK
ASSIGNED TO EXAMINER
10/04/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/26/2022
GNRT
NON-FINAL ACTION E-MAILED
05/26/2022
CNRT
NON-FINAL ACTION WRITTEN
05/26/2022
DOCK
ASSIGNED TO EXAMINER
05/23/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/07/2021
NWAP
NEW APPLICATION ENTERED
08/24/2021
Continuous trademark protection
Get notified about every new filing that threatens FRONTELYN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.